TCL Archive ODAC Calls For Tougher Standards For Accelerated Approval In Oncology By Cancer History Project February 11, 2011
TCL Archive FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart By Cancer History Project December 3, 2010
TCL Archive Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin By Cancer History Project July 23, 2010
TCL Archive ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic. By Cancer History Project April 9, 2010
TCL Archive In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit By Cancer History Project December 18, 2009
TCL Archive ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer By Cancer History Project October 9, 2009
TCL Archive ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay By Cancer History Project July 17, 2009
TCL Archive ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme By Cancer History Project April 3, 2009
ArticleSpotlight Article A Vote for Cancer: Tobacco Advertising and Presidential Elections By The Center for the Study of Tobacco and Society